Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,720.80
(
0.00%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.33
(
-0.10%
)
Bitcoin
70,997.00
(
1.57%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 163732

Tuesday, 07/09/2013 4:32:51 PM

Tuesday, July 09, 2013 4:32:51 PM

Post# of 257262

Twitter dialogue on number of pills in ABBV/ENTA’s all-oral regimen and whether it matters:




Pill burden shouldn't be an issue yet tolerability in the real world setting can only be reduced by multiple classes of DAA's including ritonavir.



[ACHN] Any further mention of sovaprevir adversely reacting with ritonavir in the DDI study?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now